Device Trial Radar · NCT05828979
Clinical Investigation to Assess a New Artificial Urinary Sphincter to Treat Urinary Incontinence in Women
Last checked: Nov 19, 2026Latest source record: Apr 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
6
Planned (sponsor's estimate)
Start
May 2, 2023
Primary completion
Jan 23, 2025
Study completion Sep 2029
Sponsor
- Lead sponsor
- UroMems SASNot on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 25, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Prospective multicenter study designed to test the feasibility of the UroMems Artificial Urinary Sphincter in women
Conditions
- Urinary Incontinence,Stress
Interventions
UroMems artificial urinary sphincterDevice
Implantation of the device
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rate of explants and revisions at 6 months after device activationTime frame: 6 months after device activation
- Rate of device activation successesTime frame: 5 weeks after device implantation
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
CHU Nantes
Nantes, France
Groupe Hospitalier Pitié-Salpêtrière
Paris, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.